NAKESHIA THOMAS: Open Payments
NPI 1164788519 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,210 in 144 payments from 17 companies in 2025. Trend: 2023 $2,516 · 2024 $2,904 · 2025 $3,210
Food & beverage: $3,095Consulting: $115
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $686 |
| Janssen Pharmaceuticals, Inc | 16 | $496 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $422 |
| Supernus Pharmaceuticals, Inc. | 14 | $332 |
| Otsuka America Pharmaceutical, Inc. | 8 | $264 |
| Alkermes, Inc. | 13 | $246 |
| Lundbeck LLC | 11 | $188 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
| Axsome Therapeutics, Inc. | 3 | $76 |
| Teva Pharmaceuticals USA, Inc. | 3 | $72 |
Products named: VRAYLAR, CAPLYTA, REXULTI, SPRAVATO, Qelbree, ARISTADA, INVEGA SUSTENNA, Auvelity.
Industry payments across VA — which companies pay providers there.
